Warning! GuruFocus detected
3 Severe warning signs
with QEN.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Centene Corp
NAICS : 524114
SIC : 6324
ISIN : US15135B1017
Share Class Description:
FRA:QEN: Ordinary SharesCompare
Compare
Traded in other countries / regions
CNC.USA0HVB.UK1CNC.ItalyCNC.MexicoQEN.GermanyC1NC34.Brazil IPO Date
2013-05-20Description
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.86 | |||||
| Equity-to-Asset | 0.32 | |||||
| Debt-to-Equity | 0.74 | |||||
| Debt-to-EBITDA | 3.13 | |||||
| Interest Coverage | 4.54 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.82 | |||||
| Beneish M-Score | -2.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.4 | |||||
| 3-Year EBITDA Growth Rate | 22.4 | |||||
| 3-Year EPS without NRI Growth Rate | 11.7 | |||||
| 3-Year Book Growth Rate | 5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 8.15 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.82 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.28 | |||||
| 9-Day RSI | 48.43 | |||||
| 14-Day RSI | 48.65 | |||||
| 3-1 Month Momentum % | -9.87 | |||||
| 6-1 Month Momentum % | -16.27 | |||||
| 12-1 Month Momentum % | -17.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.11 | |||||
| Quick Ratio | 1.11 | |||||
| Cash Ratio | 0.49 | |||||
| Days Sales Outstanding | 38.92 | |||||
| Days Payable | 33.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 5.2 | |||||
| Shareholder Yield % | 16.79 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 10.32 | |||||
| Operating Margin % | 1.96 | |||||
| Net Margin % | 2.03 | |||||
| FCF Margin % | -0.29 | |||||
| ROE % | 12.34 | |||||
| ROA % | 3.98 | |||||
| ROIC % | 3.89 | |||||
| 3-Year ROIIC % | -4.64 | |||||
| ROC (Joel Greenblatt) % | 227.23 | |||||
| ROCE % | 10.14 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.51 | |||||
| Forward PE Ratio | 8.34 | |||||
| PE Ratio without NRI | 8.36 | |||||
| Shiller PE Ratio | 18.32 | |||||
| PEG Ratio | 0.78 | |||||
| PS Ratio | 0.19 | |||||
| PB Ratio | 1.11 | |||||
| Price-to-Tangible-Book | 8.56 | |||||
| Price-to-Operating-Cash-Flow | 277.35 | |||||
| EV-to-EBIT | 6.75 | |||||
| EV-to-Forward-EBIT | 9 | |||||
| EV-to-EBITDA | 5.39 | |||||
| EV-to-Forward-EBITDA | 7.71 | |||||
| EV-to-Revenue | 0.21 | |||||
| EV-to-Forward-Revenue | 0.19 | |||||
| EV-to-FCF | -68.5 | |||||
| Price-to-GF-Value | 0.66 | |||||
| Price-to-Projected-FCF | 0.5 | |||||
| Price-to-DCF (Earnings Based) | 0.25 | |||||
| Price-to-Median-PS-Value | 0.56 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.71 | |||||
| Price-to-Graham-Number | 1.78 | |||||
| Earnings Yield (Greenblatt) % | 14.82 | |||||
| FCF Yield % | -1.61 | |||||
| Forward Rate of Return (Yacktman) % | 21.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Centene Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 151,013.582 | ||
| EPS (TTM) (€) | 5.754 | ||
| Beta | 0.47 | ||
| 3-Year Sharpe Ratio | -0.43 | ||
| 3-Year Sortino Ratio | -0.56 | ||
| Volatility % | 25.78 | ||
| 14-Day RSI | 48.65 | ||
| 14-Day ATR (€) | 0.953515 | ||
| 20-Day SMA (€) | 54.9965 | ||
| 12-1 Month Momentum % | -17.46 | ||
| 52-Week Range (€) | 53 - 72.28 | ||
| Shares Outstanding (Mil) | 496.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Centene Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Centene Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Centene Corp Frequently Asked Questions
What is Centene Corp(FRA:QEN)'s stock price today?
The current price of FRA:QEN is €55.27. The 52 week high of FRA:QEN is €72.28 and 52 week low is €53.00.
When is next earnings date of Centene Corp(FRA:QEN)?
The next earnings date of Centene Corp(FRA:QEN) is 2025-04-25.
Does Centene Corp(FRA:QEN) pay dividends? If so, how much?
Centene Corp(FRA:QEN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers